3.2 Surgical Site Infection (SSI) Prevention Bundles & Prophylactic Antibiotic Timing

Evidence-Based SSI Prevention Bundles & The SCIP Framework

Surgical site infections (SSIs) represent one of the most serious yet preventable complications in ambulatory surgery. In outpatient facilities, where patients are discharged within hours of incision, SSIs result in emergency department visits, unplanned hospital readmissions, costly re-operations, and severe patient disability. To standardize prevention, the Centers for Medicare & Medicaid Services (CMS) and the Centers for Disease Control and Prevention (CDC) established the Surgical Care Improvement Project (SCIP), which has since evolved into the core evidence-based SSI prevention bundles endorsed by AORN and the World Health Organization (WHO).

The ambulatory surgical nurse serves as the ultimate safety gatekeeper for these bundles, ensuring every element is systematically audited and executed before, during, and after surgical intervention.

The Core SCIP Infection Prophylaxis Measures

+----------------------------------------------------------------------------------------------------+
|                                 CORE SCIP INFECTION PREVENTION MEASURES                            |
+--------------+----------------------------------+--------------------------------------------------+
| Measure ID   | SCIP Clinical Metric             | Ambulatory Nursing Performance Standard          |
+--------------+----------------------------------+--------------------------------------------------+
| SCIP-Inf-1   | Prophylactic antibiotic received | Complete standard infusion within 60 minutes of |
|              | within 1 hour prior to incision  | incision; within 120 minutes for vancomycin /    |
|              |                                  | fluoroquinolones. Finish before tourniquet!      |
+--------------+----------------------------------+--------------------------------------------------+
| SCIP-Inf-2   | Prophylactic antibiotic selection| Confirm antibiotic matches procedure guidelines  |
|              | appropriate for procedure        | (e.g., Cefazolin for orthopedic/clean cases;     |
|              |                                  | Cefoxitin or Cefazolin + Flagyl for colorectal)  |
+--------------+----------------------------------+--------------------------------------------------+
| SCIP-Inf-3   | Prophylactic antibiotic          | Discontinue within 24 hours of surgical end      |
|              | discontinued within 24 hours     | time. In ASCs, prophylaxis is almost always a    |
|              |                                  | single pre-op dose. Zero post-discharge oral abx!|
+--------------+----------------------------------+--------------------------------------------------+
| SCIP-Inf-4   | Perioperative glycemic control   | Maintain perioperative blood glucose <180 mg/dL  |
|              | (blood glucose <180 mg/dL)       | via point-of-care capillary checks on admission  |
+--------------+----------------------------------+--------------------------------------------------+
| SCIP-Inf-6   | Appropriate surgical site hair   | Use electric clippers with single-use heads only |
|              | removal (no razor shaving)       | outside the OR. Razor blade shaving is banned!   |
+--------------+----------------------------------+--------------------------------------------------+
| SCIP-Inf-7   | Perioperative normothermia       | Maintain core temperature >=36.0 C (96.8 F)      |
|              | maintenance                      | using active pre-warming and intra-op forced-air |
+--------------+----------------------------------+--------------------------------------------------+
| SCIP-Inf-9   | Urinary catheter removal on      | Avoid indwelling urinary catheters in ASCs;      |
|              | Postoperative Day 1 or 2         | remove prior to PACU discharge if placed         |
+--------------+----------------------------------+--------------------------------------------------+

The Ambulatory Antimicrobial Stewardship Principle

A critical distinction in ambulatory surgery is that surgical antimicrobial prophylaxis is preventative, not therapeutic. Its sole clinical goal is achieving bactericidal drug concentrations in serum and interstitial tissue at the precise moment of incision, maintaining those levels until wound closure. Prescribing postoperative "just-in-case" oral antibiotics for routine, clean or clean-contaminated ambulatory procedures provides zero protective benefit against SSIs, fosters multidrug-resistant pathogens (such as MRSA and VRE), and exposes outpatients to severe adverse drug reactions and life-threatening Clostridioides difficile colitis.

---

Preoperative Chlorhexidine Gluconate (CHG) Bathing & Skin Antisepsis

The patient's skin is the primary reservoir for pathogens causing SSIs, predominantly gram-positive organisms such as Staphylococcus aureus (including MRSA) and Staphylococcus epidermidis. Preoperative skin preparation involves a two-tiered defense: patient-administered antiseptic bathing at home, followed by professional skin prep in the operating suite.

Home Preoperative Bathing Protocol

Chlorhexidine gluconate (CHG) is a cationic bisbiguanide antiseptic that binds electrostatically to the negatively charged bacterial cell wall, disrupting the cytoplasmic membrane and causing cellular lysis. Unlike povidone-iodine, CHG exhibits substantivity—the ability to bind firmly to the stratum corneum, creating a persistent chemical barrier with cumulative residual antimicrobial activity lasting 24 to 48 hours.

• Recommended Regimen: The CDC and AORN recommend at least two preoperative CHG showers/washes: the first on the evening prior to surgery, and the second on the morning of surgery.
• Patient Education and Application Instructions:
  1. Wash the face and hair with regular soap and shampoo first, then rinse thoroughly.
  2. Turn off the water spray. Apply 4% aqueous CHG soap or 2% CHG-impregnated cloths generously from the neck down, covering all skin surfaces, paying special attention to the planned surgical site, axillae, groin, and skin folds.
  3. Allow the CHG solution to remain on the skin (dwell time of 1 to 2 minutes) before lightly rinsing (or allow to air dry if using no-rinse wipes).
  4. Dry the skin with a freshly laundered, clean towel.
  5. Put on clean clothes and sleep on freshly washed bed linens.
  6. STRICT PROHIBITION: Do not apply any lotions, moisturizers, deodorants, perfumes, or powders after CHG bathing. Cosmetic emollients neutralize the cationic charge of CHG, entirely deactivating its persistent antimicrobial properties.
  7. CRITICAL SAFETY CONTRAINDICATIONS: CHG must NEVER contact the eyes (causes severe, irreversible toxic keratitis and permanent corneal damage) or the ears (highly ototoxic; can penetrate a non-intact tympanic membrane into the middle/inner ear, causing permanent sensorineural deafness). CHG is also contraindicated on brain tissue, meninges, or deep neural tissue.

In-Facility Surgical Skin Antisepsis & Surgical Fire Safety

In the operating room, dual-agent alcohol-based antiseptics (e.g., 2% chlorhexidine gluconate in 70% isopropyl alcohol, or 0.7% available iodine in 74% isopropyl alcohol) are strongly recommended over aqueous solutions for clean and clean-contaminated cases. The alcohol component provides immediate, broad-spectrum bactericidal kill, while the CHG or iodophor provides prolonged residual antimicrobial suppression.

• Aqueous Solutions (Povidone-Iodine): Reserved for facial, ophthalmic, otic, mucous membrane (oral/vaginal), or deep open wound preps, or for patients with documented severe hypersensitivity to CHG.
• Mandatory Dry Times & Fire Prevention: Alcohol-based preps contain volatile isopropyl alcohol (Class I flammable liquid). If vapors become trapped under surgical drapes or pooled liquid comes into contact with an electrosurgical pencil (ESU) or laser, a devastating surgical flash fire can ignite.
  • The circulating nurse must enforce a minimum 3-minute drying time on hairless skin. Hair-bearing areas, moist crevices, or large fields may require up to 1 hour or until completely dry.
  • Prevent pooling in the umbilicus, groin creases, neck folds, or beneath pneumatic tourniquets.
  • Sterile drapes and oxygen delivery devices must NOT be applied until the prep has fully dried and all flammable vapors have dissipated. The circulating nurse verbally confirms "prep is dry and vapors cleared" during the surgical time-out.

---

Surgical Site Hair Management

Hair removal is one of the most historically misunderstood aspects of infection control. Surgical hair is not inherently contaminated; removing it frequently causes far more harm than leaving it intact.

The Golden Rule: Leave Hair Intact

AORN and CDC guidelines mandate: Do NOT remove hair unless it directly interferes with the surgical incision, wound visualization, or adhesive dressing adhesion.

The Strict Prohibition of Razor Shaving

Shaving with a razor blade is strictly banned in modern ambulatory surgical practice. Razors create hundreds of microscopic epidermal cuts, nicks, and micro-abrasions. Skin bacteria rapidly colonize these abrasions, multiplying in the warm, serous exudate within hours. Clinical trials prove that shaving with a razor doubles to triples the rate of surgical site infection compared to clipping or leaving hair intact.

Electric Clippers with Single-Use Disposable Heads

When hair removal is unavoidable, it must be performed using an electric surgical clipper with a single-use, disposable blade head:

• Technique: Hold the clipper blade flat and parallel against the skin surface. Glide smoothly across the skin without pressing the cutting teeth down, which prevents skin scraping.
• Location Mandate: Hair clipping MUST be performed in the preoperative holding area, NEVER inside the operating room suite. Clipping inside the OR disperses millions of microscopic hair fragments, keratin dander, and bacterial squames into room air currents, which settle directly onto exposed sterile tables, instrument basins, and open surgical wounds.
• Cleanup: Immediately capture loose clipped hair from the patient's skin using an adhesive tape strip, sticky lint roller, or specialized vacuum-assisted clipper shroud before transferring the patient to the OR table.

+----------------------------------------------------------------------------------------------------+
|                                 SURGICAL SITE HAIR MANAGEMENT STANDARDS                            |
+---------------------+-----------------------------+------------------------------------------------+
| Method              | Clinical Status             | Clinical Rationale                             |
+---------------------+-----------------------------+------------------------------------------------+
| No Removal          | Preferred Standard          | Zero skin trauma; lowest baseline SSI rate     |
+---------------------+-----------------------------+------------------------------------------------+
| Electric Clippers   | Allowed Only When Essential | Single-use head; no epidermal abrasions;       |
| (Disposable Head)   | (In Pre-Op Holding Only)    | prevents bacterial proliferation               |
+---------------------+-----------------------------+------------------------------------------------+
| Razor Blade Shaving | STRICTLY PROHIBITED         | Causes epidermal micro-cuts; bacteria rapidly  |
|                     | (SCIP & AORN Contraindicated)| colonize nicks; triples SSI risk               |
+---------------------+-----------------------------+------------------------------------------------+
| Chemical Depilatory | Rare Alternative            | Risk of contact dermatitis; requires 15-20 min |
|                     | (Requires Sensitivity Test) | dwell time; rarely used in fast-paced ASCs     |
+---------------------+-----------------------------+------------------------------------------------+

Prophylactic Antibiotic Administration Timing, Dosing & Redosing

For surgical antibiotic prophylaxis to be effective, bactericidal concentrations must be established in tissue fluid at the moment the knife divides the epidermis. Administering an antibiotic after incision provides markedly inferior protection, as bacteria have already seeded the incision site.

The Two Precision Timing Windows

1. Standard 60-Minute Infusion Window: For all beta-lactams (cephalosporins, penicillins, ampicillin/sulbactam), clindamycin, metronidazole, and aminoglycosides, the IV infusion must be fully completed within 60 minutes prior to surgical incision. The clinical target is completing the infusion 15 to 45 minutes prior to incision, allowing peak tissue distribution.
2. Extended 120-Minute Infusion Window: For vancomycin and fluoroquinolones (ciprofloxacin, levofloxacin), the infusion must begin and be administered within 120 minutes prior to surgical incision.
   • The Vancomycin Infusion Safety Rule: Vancomycin requires extended administration because it must be infused slowly—at a rate of at least 60 minutes per 1 gram (1.5 grams over 90 minutes; 2 grams over 120 minutes). Rapid IV push or hurried infusion triggers catastrophic, non-immune-mediated histamine degranulation from mast cells, causing Red Man Syndrome (severe flushing of the face, neck, and upper torso, intense pruritus, urticaria, bronchospasm, and profound cardiovascular collapse). In an ASC, vancomycin must be initiated in pre-op holding well in advance of the scheduled incision time.

The Extremity Pneumatic Tourniquet Rule

In orthopedic, podiatry, and reconstructive plastic procedures involving an extremity pneumatic tourniquet (e.g., knee arthroscopy, open reduction of ankle fracture, carpal tunnel release), the entire prophylactic antibiotic infusion MUST be 100% completed at least 5 to 10 minutes BEFORE the tourniquet cuff is inflated. Once the tourniquet is pressurized above systolic pressure (typically 100 mmHg above systolic for legs, 50 mmHg above for arms), arterial circulation to the operative extremity is completely cut off. Any antibiotic infused after tourniquet inflation remains trapped in the systemic circulation, leaving the surgical site with zero drug tissue penetration.

Weight-Based Dosing Standards

Fixed "one-size-fits-all" antibiotic dosing is obsolete. Under-dosing obese outpatients results in subtherapeutic tissue concentrations in adipose tissue beds, directly causing SSI breakthrough.

• Cefazolin (Ancef):
  • Adult weight <120 kg (<264 lbs): 2 grams IV.
  • Adult weight >=120 kg (>=264 lbs): 3 grams IV.
  • Pediatric dosing: 30 mg/kg IV (maximum 2 grams).
• Vancomycin: Weight-based at 15 mg/kg IV (maximum single dose 2 grams).

Intraoperative Redosing Protocols

Intraoperative antimicrobial redosing is mandatory when either of two clinical triggers occurs:

1. Prolonged Surgical Duration: When the surgery exceeds two elimination half-lives ($2 \times t_{1/2}$) of the antimicrobial agent, measured from the initiation of the preoperative dose.
2. Massive Blood Loss: When intraoperative blood loss exceeds 1,500 mL in an adult patient, which dramatically dilutes intravascular drug volume.

+---------------------------------------------------------------------------------------------------------+
|                         SURGICAL ANTIMICROBIAL PROPHYLAXIS DOSING & REDOSING TABLE                      |
+---------------------+-------------------+---------------------+-----------------------------------------+
| Antimicrobial Agent | Elimination t 1/2 | Standard Adult Dose | Intraoperative Redosing Interval        |
+---------------------+-------------------+---------------------+-----------------------------------------+
| Cefazolin (Ancef)   | 1.8 - 2.0 hours   | 2 g (<120 kg)       | EVERY 4 HOURS                           |
|                     |                   | 3 g (>=120 kg)      | (Calculated from initial dose start)    |
+---------------------+-------------------+---------------------+-----------------------------------------+
| Cefoxitin (Mefoxin) | 0.7 - 1.0 hour    | 2 g IV              | EVERY 2 HOURS                           |
+---------------------+-------------------+---------------------+-----------------------------------------+
| Cefotetan (Cefotan) | 3.0 - 4.0 hours   | 2 g IV              | EVERY 6 HOURS                           |
+---------------------+-------------------+---------------------+-----------------------------------------+
| Ampicillin/Sulbactam| 1.0 hour          | 3 g IV              | EVERY 2 HOURS                           |
| (Unasyn)            |                   | (2g amp / 1g sulb)  |                                         |
+---------------------+-------------------+---------------------+-----------------------------------------+
| Clindamycin         | 2.0 - 4.0 hours   | 900 mg IV           | EVERY 6 HOURS                           |
| (Cleocin)           |                   |                     |                                         |
+---------------------+-------------------+---------------------+-----------------------------------------+
| Vancomycin          | 4.0 - 8.0 hours   | 15 mg/kg IV         | >10 - 12 HOURS                          |
|                     |                   | (max 2 g)           | (Rarely if ever redosed in ASCs)        |
+---------------------+-------------------+---------------------+-----------------------------------------+
| Gentamicin          | 2.0 - 3.0 hours   | 5 mg/kg IV          | SINGLE DOSE ONLY                        |
|                     |                   | (once daily dose)   | (No intra-op redose indicated)          |
+---------------------+-------------------+---------------------+-----------------------------------------+
| Metronidazole       | 8.0 hours         | 500 mg IV           | >8 HOURS                                |
| (Flagyl)            |                   |                     | (No intra-op redose indicated in ASCs)  |
+---------------------+-------------------+---------------------+-----------------------------------------+

---

Perioperative Normothermia Maintenance & Glycemic Control

Two critical physiological variables—core body temperature and blood glucose—directly regulate host defense mechanisms and wound healing kinetics during outpatient surgery.

Perioperative Normothermia Maintenance (>=36.0°C / 96.8°F)

Normothermia maintenance is an audited SCIP and CMS quality indicator. A decrease in core body temperature below 36.0°C compromises host defenses through multiple physiological pathways:

• Subcutaneous Vasoconstriction & Tissue Hypoxia: Mild hypothermia triggers profound sympathetic alpha-adrenergic peripheral vasoconstriction, slashing capillary blood flow to the surgical wound. Decreased subcutaneous tissue oxygen tension ($P_tO_2$) starves polymorphonuclear neutrophils of the oxygen required to generate superoxide radicals via NADPH oxidase, disabling oxidative bacterial killing and tripling SSI risk.
• Suppressed Collagen Synthesis: Hypothermia impairs fibroblast proliferation and decreases enzymatic cross-linking of newly synthesized collagen, undermining wound tensile strength and predisposing outpatients to wound dehiscence.
• Coagulopathy: Hypothermia reversibly disables platelet glycoprotein Ib-IX-V receptors, blocks von Willebrand factor binding, and retards the enzymatic cascades of coagulation. For every 1.0°C drop in temperature, intraoperative blood loss increases by 16% and transfusion risk jumps by 22%.
• Shivering & Cardiac Ischemia: In Phase I recovery, post-anesthetic shivering increases whole-body oxygen consumption by up to 400%, generating dangerous lactic acidosis, hypercarbia, and myocardial ischemia in patients with underlying coronary artery disease.
• Ambulatory Active Warming Strategies:
  • Pre-warming: Administering 15 to 30 minutes of forced-air warming in pre-op holding prior to induction dilates peripheral vasculature, elevating peripheral tissue heat content and preventing the core-to-peripheral redistribution temperature drop upon anesthetic induction.
  • Intraoperative Warming: Applying forced-air warming blankets over all non-operative body surfaces, warming IV fluids for infusions >500 mL, utilizing warmed surgical irrigation fluids (maintained at 37°C in calibrated warmers), and keeping ambient OR temperatures between 68°F and 73°F (20°C to 23°C).

Perioperative Glycemic Control (<180 mg/dL / 10.0 mmol/L)

Acute perioperative hyperglycemia impairs cellular immune function, regardless of whether the patient has a diagnosed history of diabetes mellitus:

• Pathophysiology of Hyperglycemia on Wound Healing: Blood glucose levels >=180 mg/dL cause non-enzymatic glycosylation of circulating immunoglobulins, suppress complement activation, impair leukocyte chemotaxis, and blunt intracellular phagocytic killing. Hyperglycemia also damages vascular endothelial glycocalyx integrity, causing fluid shifts and microvascular ischemia.
• ASC Glycemic Protocols: Every patient with diabetes mellitus or suspected undiagnosed hyperglycemia must undergo point-of-care capillary blood glucose testing upon admission to pre-op holding. Blood glucose levels exceeding 180 mg/dL should be treated with subcutaneous rapid-acting insulin per validated facility sliding scale or physician protocol. If an outpatient presents on the morning of surgery with a blood glucose >250 to 300 mg/dL, especially with ketonuria, severe dehydration, or signs of hyperosmolar crisis, elective ambulatory surgery must be postponed for medical stabilization.